{"id":519927,"date":"2021-07-29T08:33:57","date_gmt":"2021-07-29T12:33:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/"},"modified":"2021-07-29T08:33:57","modified_gmt":"2021-07-29T12:33:57","slug":"galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/","title":{"rendered":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">TEL AVIV, Israel<\/span>, <span class=\"xn-chron\">July 29, 2021<\/span> \/PRNewswire\/ &#8212; Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (&#8220;Galmed&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis announced today that it will\u00a0host a conference call and webcast on <span class=\"xn-chron\">Thursday, August 5, 2021<\/span>, to provide an update on current developments with respect to its clinical programs for Aramchol\u2122 and to discuss financial results for the quarter ended\u00a0June 30, 2021. \u00a0<\/p>\n<p>\u00a0<\/p>\n<div id=\"prni_dvprnejpg6849left\" dir=\"ltr\">\n        <img decoding=\"async\" id=\"prnejpg6849left\" title=\"Galmed Pharmaceuticals Ltd Logo\" border=\"0\" alt=\"Galmed Pharmaceuticals Ltd Logo\" align=\"middle\" src=\"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\" \/>\n      <\/div>\n<p>\u00a0<\/p>\n<p>\n        <b><br \/>\n          <i>Conference Call &amp; Webcast:<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>\n        <b><br \/>\n          <i><br \/>\n            <u><br \/>\n              <span class=\"xn-chron\">Thursday August 5, 2021<\/span>, <span class=\"xn-chron\">8:30 AM ET<\/span><\/u><br \/>\n          <\/i><br \/>\n        <\/b>\n      <\/p>\n<p>Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-888-394-8218<br \/>Toll\/International:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1-323-701-0225<br \/>Israel Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 809 212 883<br \/>Conference ID:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2905012\u00a0\u00a0<br \/>Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<b><a target=\"_blank\" href=\"http:\/\/public.viavid.com\/index.php?id=145911\" rel=\"nofollow noopener\">http:\/\/public.viavid.com\/index.php?id=145911<\/a><\/b><\/p>\n<p>\n        <b><br \/>\n          <i>Replay Dial-In Numbers<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1-844-512-2921<br \/>Toll\/International:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a01-412-317-6671<br \/>Replay Pin Number:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a02905012<br \/>Replay Start:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Thursday August 5, 2021, <span class=\"xn-chron\">11:30 AM ET<\/span><br \/>Replay Expiry:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span class=\"xn-chron\">Thursday August 19, 2021<\/span>, <span class=\"xn-chron\">11:59 PM ET<\/span><\/p>\n<p>\n        <b><br \/>\n          <i>About Aramchol and Non-alcoholic Steatohepatitis (NASH)<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>Aramchol (arachidyl amido cholanoic acid) is a novel fatty acid bile acid conjugate, inducing beneficial modulation of intra-hepatic lipid metabolism. Aramchol&#8217;s ability to modulate hepatic lipid metabolism was discovered and validated in animal models, demonstrating downregulation of the three key pathologies of NASH: steatosis, inflammation and fibrosis. The effect of Aramchol on fibrosis is mediated by downregulation of steatosis and directly on human collagen producing cells. Aramchol has been granted Fast Track designation status by the FDA for the treatment of NASH.<\/p>\n<p>NASH is an emerging world crisis impacting an estimated 3% to 5% of the U.S. population and an estimated 2% to 4% globally. It is the fastest growing cause of liver cancer and liver transplant in the U.S. due to the rise in obesity. NASH is the progressive form of non-alcoholic fatty liver disease that can lead to cardiovascular disease, cirrhosis and liver-related mortality.<\/p>\n<p>\n        <b><br \/>\n          <i>About Galmed Pharmaceuticals Ltd.<\/i><br \/>\n        <\/b>\n      <\/p>\n<p>Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Our lead compound, Aramchol\u2122, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study. We are also collaborating with the\u00a0Hebrew University\u00a0in the development of Amilo-5MER, a 5 amino acid synthetic peptide and recently initiated a first in human study.<\/p>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LN50594&amp;sd=2021-07-29\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5-301344113.html\">https:\/\/www.prnewswire.com\/news-releases\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5-301344113.html<\/a><\/p>\n<p>SOURCE  Galmed Pharmaceuticals Ltd.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN50594&amp;Transmission_Id=202107290830PR_NEWS_USPR_____LN50594&amp;DateId=20210729\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire TEL AVIV, Israel, July 29, 2021 \/PRNewswire\/ &#8212; Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (&#8220;Galmed&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis announced today that it will\u00a0host a conference call and webcast on Thursday, August 5, 2021, to provide an update on current developments with respect to its clinical programs for Aramchol\u2122 and to discuss financial results for the quarter ended\u00a0June 30, 2021. \u00a0 \u00a0 \u00a0 Conference Call &amp; Webcast: Thursday August 5, 2021, 8:30 AM ET Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-888-394-8218Toll\/International:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1-323-701-0225Israel Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 809 212 883Conference ID:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2905012\u00a0\u00a0Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0http:\/\/public.viavid.com\/index.php?id=145911 Replay &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-519927","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire TEL AVIV, Israel, July 29, 2021 \/PRNewswire\/ &#8212; Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (&#8220;Galmed&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis announced today that it will\u00a0host a conference call and webcast on Thursday, August 5, 2021, to provide an update on current developments with respect to its clinical programs for Aramchol\u2122 and to discuss financial results for the quarter ended\u00a0June 30, 2021. \u00a0 \u00a0 \u00a0 Conference Call &amp; Webcast: Thursday August 5, 2021, 8:30 AM ET Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-888-394-8218Toll\/International:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1-323-701-0225Israel Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 809 212 883Conference ID:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2905012\u00a0\u00a0Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0http:\/\/public.viavid.com\/index.php?id=145911 Replay &hellip; Continue reading &quot;Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-29T12:33:57+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5\",\"datePublished\":\"2021-07-29T12:33:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/\"},\"wordCount\":396,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/595923\\\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/\",\"name\":\"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/595923\\\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\",\"datePublished\":\"2021-07-29T12:33:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#primaryimage\",\"url\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/595923\\\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\",\"contentUrl\":\"http:\\\/\\\/mma.prnewswire.com\\\/media\\\/595923\\\/Galmed_Pharmaceuticals_Ltd_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/","og_locale":"en_US","og_type":"article","og_title":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk","og_description":"PR Newswire TEL AVIV, Israel, July 29, 2021 \/PRNewswire\/ &#8212; Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (&#8220;Galmed&#8221; or the &#8220;Company&#8221;), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, currently in Phase 3 clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis announced today that it will\u00a0host a conference call and webcast on Thursday, August 5, 2021, to provide an update on current developments with respect to its clinical programs for Aramchol\u2122 and to discuss financial results for the quarter ended\u00a0June 30, 2021. \u00a0 \u00a0 \u00a0 Conference Call &amp; Webcast: Thursday August 5, 2021, 8:30 AM ET Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a01-888-394-8218Toll\/International:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1-323-701-0225Israel Toll Free:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 809 212 883Conference ID:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2905012\u00a0\u00a0Webcast:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0http:\/\/public.viavid.com\/index.php?id=145911 Replay &hellip; Continue reading \"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-29T12:33:57+00:00","og_image":[{"url":"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5","datePublished":"2021-07-29T12:33:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/"},"wordCount":396,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#primaryimage"},"thumbnailUrl":"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/","name":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#primaryimage"},"thumbnailUrl":"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg","datePublished":"2021-07-29T12:33:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#primaryimage","url":"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg","contentUrl":"http:\/\/mma.prnewswire.com\/media\/595923\/Galmed_Pharmaceuticals_Ltd_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/galmed-pharmaceuticals-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-thursday-august-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Galmed Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Business Update on Thursday August 5"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=519927"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519927\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=519927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=519927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=519927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}